FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer

 
Share
 

Manage episode 200758340 series 1452688
By Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio streamed directly from their servers.

FDA medical oncologists discuss the FDA approvals of brigatinib and ceritinib for ALK-positive non-small cell lung cancer.

Released July 25, 2017

135 episodes available. A new episode about every 33 days averaging 0 mins duration .